HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Klaus Klumpp Selected Research

asapiprant

1/2022Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19.
4/2021Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Klaus Klumpp Research Topics

Disease

21Infections
01/2022 - 04/2007
7Human Influenza (Influenza)
09/2013 - 03/2003
2COVID-19
01/2022 - 04/2021
2Chronic Hepatitis B
03/2014 - 12/2012
2HIV Infections (HIV Infection)
07/2008 - 01/2006
1Hepatitis B
04/2019
1Fibrosis (Cirrhosis)
04/2019
1Hepatitis C
01/2018
1Neoplasms (Cancer)
11/2014
1Virus Diseases (Viral Diseases)
04/2014
1Viremia
05/2013
1Fever (Fevers)
05/2013
1Dengue (Dengue Fever)
05/2013
1Influenza in Birds (Avian Flu)
11/2011
1Chronic Hepatitis C
08/2008

Drug/Important Bio-Agent (IBA)

11Antiviral Agents (Antivirals)IBA
04/2019 - 03/2003
4RNA (Ribonucleic Acid)IBA
01/2019 - 01/2014
3Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2019
3Pharmaceutical PreparationsIBA
11/2021 - 05/2013
3NVR 3-778IBA
04/2019 - 01/2018
3AntigensIBA
04/2019 - 03/2014
3AntibodiesIBA
01/2018 - 12/2012
3Oseltamivir (Tamiflu)FDA Link
11/2011 - 01/2006
3NucleosidesIBA
08/2008 - 01/2008
2asapiprantIBA
01/2022 - 04/2021
2EicosanoidsIBA
01/2022 - 04/2021
2Messenger RNA (mRNA)IBA
01/2022 - 09/2013
2CytokinesIBA
12/2019 - 09/2012
2DNA (Deoxyribonucleic Acid)IBA
01/2019 - 01/2018
2peginterferon alfa-2a (Pegasys)FDA Link
10/2013 - 08/2008
2Protease Inhibitors (Protease Inhibitor)IBA
10/2013 - 07/2008
2EndonucleasesIBA
09/2013 - 03/2003
2balapiravirIBA
05/2013 - 08/2008
2Neuraminidase (Sialidase)IBA
01/2013 - 01/2006
1Phospholipases A2 (Phospholipase A2)IBA
01/2022
1Phospholipases (Phospholipase)IBA
01/2022
1Prostaglandin D2IBA
01/2022
1prostaglandin D2 receptorIBA
01/2022
1Prostaglandins DIBA
04/2021
1COVID-19 VaccinesIBA
04/2021
1VaccinesIBA
04/2021
1Hepatitis B e AntigensIBA
04/2019
1Tetraspanin 28IBA
01/2018
1entecavirFDA Link
01/2018
1InterferonsIBA
01/2018
1Monoclonal AntibodiesIBA
04/2015
1Phosphotransferases (Kinase)IBA
11/2014
1Protein Kinases (Protein Kinase)IBA
11/2014
1Biological ProductsIBA
11/2014
1Viral ProteinsIBA
04/2014
1Interferon-alpha (Interferon Alfa)IBA
03/2014
1RibonucleoproteinsIBA
09/2013
1EnzymesIBA
01/2013
1N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2013
1HLA-A Antigens (HLA-A)IBA
12/2012
1EpitopesIBA
12/2012
1HLA Antigens (Human Leukocyte Antigens)IBA
12/2012
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2012
1Interferon Type IIBA
09/2012
1peramivirIBA
10/2010
14'-azidocytidineIBA
12/2008
12'- fluoro- 2'- methyl- 3',5'- diisobutyryldeoxycytidineIBA
12/2008
12'-deoxy-2'-fluoro-2'-C-methylcytidineIBA
12/2008
1ProdrugsIBA
12/2008
1Ribavirin (Virazole)FDA LinkGeneric
08/2008
1Reverse Transcriptase InhibitorsIBA
07/2008
1efavirenz (Sustiva)FDA Link
07/2008
1ProTidesIBA
04/2007
1phosphoramidic acidIBA
04/2007
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
01/2006
1Eukaryotic Initiation Factor-4EIBA
05/2003
17-methylguanosine triphosphateIBA
05/2003
1triphosphoric acid (triphosphate)IBA
05/2003

Therapy/Procedure

1Combination Drug Therapy (Combination Chemotherapy)
10/2010
1Therapeutics
07/2008